Volume 70, Issue 4, Pages (August 2006)

Slides:



Advertisements
Similar presentations
Volume 72, Issue 7, Pages (October 2007)
Advertisements

Volume 65, Issue 1, Pages (January 2004)
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
by Yong Du, Aqing Yao, Dengfu Guo, Tadashi Inagami, and Donna H. Wang
Volume 66, Issue 1, Pages (July 2004)
Volume 64, Issue 6, Pages (December 2003)
Volume 72, Issue 3, Pages (August 2007)
Volume 65, Issue 1, Pages (January 2004)
Volume 69, Issue 3, Pages (February 2006)
Volume 69, Issue 6, Pages (March 2006)
Volume 68, Issue 2, Pages (August 2005)
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Volume 68, Issue 6, Pages (December 2005)
Volume 56, Issue 3, Pages (September 1999)
Furosemide stimulates macula densa cyclooxygenase-2 expression in rats
Volume 54, Issue 3, Pages (September 1998)
Volume 60, Issue 6, Pages (December 2001)
Li Cui, Raymond K. Blanchard, Robert J. Cousins  Kidney International 
Volume 57, Issue 2, Pages (October 2000)
Smad7 gene transfer inhibits peritoneal fibrosis
Volume 68, Issue 6, Pages (December 2005)
Volume 61, Issue 2, (February 2002)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 83, Issue 5, Pages (May 2013)
Volume 65, Issue 1, Pages (January 2004)
Volume 61, Issue 5, Pages (May 2002)
Volume 65, Issue 4, Pages (April 2004)
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 73, Issue 4, Pages (February 2008)
Volume 63, Issue 4, Pages (April 2003)
Expression of HIV transgene aggravates kidney injury in diabetic mice
Volume 59, Issue 5, Pages (May 2001)
Volume 61, Issue 5, Pages (May 2002)
Volume 55, Issue 4, Pages (April 1999)
Volume 73, Issue 2, Pages (January 2008)
Volume 69, Issue 6, Pages (March 2006)
Magnus Åbrink, Eric Larsson, Anders Gobl, Lars Hellman 
Volume 72, Issue 3, Pages (August 2007)
Volume 71, Issue 11, Pages (June 2007)
Akito Maeshima, Yoshihisa Nojima, Itaru Kojima  Kidney International 
Volume 60, Issue 6, Pages (December 2001)
Volume 57, Issue 3, Pages (March 2000)
Volume 79, Issue 4, Pages (February 2011)
Volume 70, Issue 10, Pages (November 2006)
Volume 65, Issue 2, Pages (February 2004)
Volume 66, Issue 1, Pages (July 2004)
Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells  Z. Su, J. Zimpelmann, K.D. Burns  Kidney.
Volume 73, Issue 6, Pages (March 2008)
Volume 70, Issue 1, Pages (July 2006)
Volume 54, Issue 4, Pages (October 1998)
Volume 66, Issue 5, Pages (November 2004)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 72, Issue 7, Pages (October 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Distribution of postsynaptic density proteins in rat kidney: Relationship to neuronal nitric oxide synthase  Akihiro Tojo, David S. Bredt, Christopher.
STAT proteins mediate angiotensin II–induced production of TIMP-1 in human proximal tubular epithelial cells  Xiangmei Chen, Jianzhong Wang, Feng Zhou,
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 73, Issue 3, Pages (February 2008)
Volume 69, Issue 11, Pages (June 2006)
Volume 73, Issue 3, Pages (February 2008)
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Endothelin antagonists in renal disease
Volume 56, Issue 6, Pages (December 1999)
Volume 70, Issue 3, Pages (August 2006)
Volume 72, Issue 11, Pages (December 2007)
Cell cycle regulation: Repair and regeneration in acute renal failure
Volume 58, Issue 6, Pages (December 2000)
Volume 70, Issue 1, Pages (July 2006)
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 70, Issue 4, Pages 641-646 (August 2006) Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats  Y. Kaneshiro, A. Ichihara, T. Takemitsu, M. Sakoda, F. Suzuki, T. Nakagawa, M. Hayashi, T. Inagami  Kidney International  Volume 70, Issue 4, Pages 641-646 (August 2006) DOI: 10.1038/sj.ki.5001627 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Transgene of human protein receptor (hProRenRC). (a) Representative semiquantitative RT-PCR products of hProRenRc gene and its quantitative analysis by real-time RT-PCR in the various tissues of no. 21 line (▪) and no. 29 line (□) of Tg rats. (b) Renal localization of hProRenRc transgene assessed by in situ hybridization in wild-type (wild) rats and Tg rats with antisense and sense probes. The high magnification photograph shows that the majority of the transgene was expressed in tubular cells including macula densa as shown by a big arrow, and a few were observed in the glomerular epithelium as shown by small arrows. Kidney International 2006 70, 641-646DOI: (10.1038/sj.ki.5001627) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Renal cortical COX-2 expression. (a) Renal cortical COX-2 mRNA expression measured by real-time PCR and (b) representative Western blotting and quantitative analysis of COX-2 protein expression in Tg rats (n=6) and wild-type rats (wild, n=6). *P<0.05 versus wild. Kidney International 2006 70, 641-646DOI: (10.1038/sj.ki.5001627) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 COX-2-dependent renal blood flow. Representative COX-2 immunostaining in the renal cortex of Tg and wild-type (wild) rats. Bar=25μm. As shown by arrows, stronger COX-2 staining was observed in the Tg group than in the wild group. Kidney International 2006 70, 641-646DOI: (10.1038/sj.ki.5001627) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 COX-2-dependent renal blood flow. (a) Change in renal blood flow assessed by electromagnetic flow probe measurement and (b) percent (%) change in renal cortical blood flow assessed by fiber-optic blood flow measurement before (0ng/g bw NS398) and after administration of 1 and 10ng/g bw NS398 to Tg rats (n=6, •) and wild-type rats (n=4, ○). *P<0.05 versus 0ng/g bw NS398, †P<0.05 versus the response in wild-type rats. Kidney International 2006 70, 641-646DOI: (10.1038/sj.ki.5001627) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Representative Western blotting of phosphorylated ERK and total ERK and quantitative analysis by the ratio of phosphorylated ERK to total ERK in the renal cortex from Tg rats (n=6) and wild-type rats (wild, n=6). *P<0.05 versus wild. Kidney International 2006 70, 641-646DOI: (10.1038/sj.ki.5001627) Copyright © 2006 International Society of Nephrology Terms and Conditions